Research Letter
Alitretinoin: treatment for refractory palmoplantar keratoderma
H.K. Park,
H.K. Park
Department of Dermatology, Hanyang University College of Medicine, Seoul, 133-792 South Korea
Search for more papers by this author E.J. Kim,
E.J. Kim
Department of Dermatology, Hanyang University College of Medicine, Seoul, 133-792 South Korea
Search for more papers by this author J.Y. Ko,
Corresponding Author
J.Y. Ko
Department of Dermatology, Hanyang University College of Medicine, Seoul, 133-792 South Korea
Correspondence: Joo Yeon Ko.
E-mail: [email protected]
Search for more papers by this author
H.K. Park,
H.K. Park
Department of Dermatology, Hanyang University College of Medicine, Seoul, 133-792 South Korea
Search for more papers by this author E.J. Kim,
E.J. Kim
Department of Dermatology, Hanyang University College of Medicine, Seoul, 133-792 South Korea
Search for more papers by this author J.Y. Ko,
Corresponding Author
J.Y. Ko
Department of Dermatology, Hanyang University College of Medicine, Seoul, 133-792 South Korea
Correspondence: Joo Yeon Ko.
E-mail: [email protected]
Search for more papers by this author
First published: 30 November 2015
No abstract is available for this article.
References
- 1Oh YJ, Lee HE, Ko JY et al. A sporadic case of mal de Meleda caused by gene mutation in SLURP-1 in Korea. Ann Dermatol 2011; 23: 396–9.
- 2Van de Kerkhof PCM, Van Dooren-Greebe RJ, Steijlen PM. Acitretin in the treatment of mal de Meleda. Br J Dermatol 1992; 127: 191–2.
- 3Ortiz NE, Nijhawan RI, Weinberg JM. Acitretin. Dermatol Ther 2013; 26: 390–9.
- 4Raone B, Raboni R, Patrizi A. Alitretinoin: a new treatment option for hereditary punctate palmoplantar keratoderma (Brauer–Buschke–Fischer syndrome). J Am Acad Dermatol 2014; 71: e48–9.
- 5Schmitt-Hoffmann AH, Roos B, Schoetzau A et al. Oral alitretinoin: a review of the clinical pharmacokinetics and pharmacodynamics. Expert Rev Clin Pharmacol 2012; 5: 373–88.
